²é¿´: 893  |  »Ø¸´: 0

»ù´¡ÉúÎïʵÑéÍâ°

гæ (³õÈëÎÄ̳)

[½»Á÷] ÂöÂçĤÐÂÉúѪ¹Ü¶¯ÎïÄ£Ð͵Ĺ¹½¨

//
¶¯ÎïµÄÑ¡Ôñ


Ö÷ÒªÓÐÊó¡¢ÍúͺïµÈ¡£ÊóÊÇĿǰÓÕµ¼CNVÄ£ÐÍÓ¦ÓÃ×î¹ã·ºµÄʵÑ鶯Îï¡£

Êó

ÊóÓÕµ¼CNVµÄ·¢ÉúÂʽϸߣ¬´óÔ¼ÓÐ60£¥¡«70£¥ÔÚ¹âÄýºó¶Ìʱ¼ä£¨1ÖÜ£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¹âÄý°ßÓ«¹âÉøÂ©10¡«14Ìì´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬±ãÓÚ»ùÒò²Ù×÷£¬¿ÉÓÃÓڹ۲쵥һ»ùÒò¹ý±í´ï»òµÍ±í´ï¶ÔCNVÉú³ÉµÄÓ°Ïì¡£

²»×ãÖ®´¦ÊÇFFAÖй۲쵽µÄÐÂÉúѪ¹ÜÉøÂ©Âʵͣ¬½öΪ28£¥£¬ÇÒÊóµÄÑÛÇò½ÏС£¬²Ù×÷¼¼ÊõÒªÇó¸ß¡£´óÊóºÍСÊóCNVµÄÓÕ·¢ÂÊÎÞÃ÷ÏÔ²îÒ죬СÊóÑÛÇò¸üС£¬²Ù×÷ÒªÇó¸ü¸ß£¬¸üÊÊÓÚ½øÐÐÓйػùÒòÇóý·½ÃæµÄÑо¿¡£

ºï

ʵÑéÐÔºïCNVÄ£ÐÍÓëÈËÀ༲²¡¸Ä±ä¼«ÎªÏàËÆ£¬²»½ö×é֯ѧ¸Ä±äÒ»Ö£¬ÔÚÑÛµ×Ó«¹âËØÑª¹ÜÔìÓ°£¨FFA£©ÖÐÒ²¾ßÓÐÓ«¹âËØÉøÂ©µÄÌØÕ÷¡£ÕâÖÖÐÂÉúѪ¹ÜÒ»°ã·¢ÉúÔÚ¼¤¹â¹âÄýºó4ÖÜ£¬¿É³ÖÐø2¡«52ÖÜ¡£ÔöÉúÒÆÐеÄRPEϸ°û°üÈÆÐÂÉúѪ¹Üºó£¬ÐÂÉúѪ¹ÜÓ«¹âËØÉøÂ©µÄ±íÏÖ»áÔ½À´Ô½²»Ã÷ÏÔ¡£

¾¡¹ÜÕâÖÖÄ£Ð͵õ½ÁËÒ»ÖµÄÈϿɣ¬µ«¶¯ÎïÀ´Ô´ÊÜÏÞ£¬·ÑÓýϸߣ¬CNVÓÕ·¢Ê±¼ä½Ï³¤£¬·¢ÉúÂʵͣ¬ÏÞÖÆÁËÆäÓ¦Óá£

ÍÃ

ÍòúÉúµÄCNVÔÚFFAÖв»¾ßÓÐÓ«¹âËØÉøÂ©µÄÌØÕ÷£¬¼ÓÖ®¿¼Âǵ½ÍõÄÑÛµ×Ѫѭ»·½á¹¹ÓëÈËÀàÓнϴóµÄ²îÒ죬ĿǰÒÑ»ù±¾²»ÓÃÍÃ×ö´ËÀàÄ£ÐÍ¡£

//
ÔìÄ£·½·¨


Ò»
¼¤¹âÓÕµ¼¶¯ÎïÄ£ÐÍ

ÔìÄ£·½·¨£º

½¡¿µ×ØÉ«Å²Íþ´óÊó£¬ÐÛÐÔ£¬ÌåÖÊÁ¿180-200g£¬10%Ë®ºÏÂÈÈ©(0.35mL/100gÌåÖÊÁ¿)¸¹Ç»×¢ÉäÂé×í¡£¸´·½ÍÐßÁ¿¨°·µÎÑÛÒºµãÑÛɢͫ¡£ÑÛǰ·ÅÖõμÓÉÙÁ¿ 1%¼×»ùÏËÎ¬ËØµÄ¸Ç²£Æ¬½Ó´¥½ÇĤ£¬ë´¼¤¹â(²¨³¤647nm£¬¹â°ßÖ±¾¶50um£¬¹¦ÂÊ360mW£¬ÆØ¹âʱ¼ä0.05s)¾àÊÓÅÌ2~3¸öÊÓÅÌÖ±¾¶¾ùÔȹâÄý9¸öµã£¬ÒÔ¼ûµ½ÓÐÆøÅݲúÉúÌáʾBruchĤ±»»÷´©Îª×¼¡£



FFAµÄ¹Û²ì£º

¹âÄýºóµÚ3¡¢7¡¢14¡¢21¡¢30dËæ»úѡȡ4Ö»´óÊóÐÐFFA¼ì²é¡£É¢Í«¼°Âé×í·½·¨Í¬Ç°£¬10%Ó«¹âËØÄÆ×¢ÉäÒº0.5mL/kg¸¹Ç»×¢ÉäºóÁ¢¼´ÐÐFFA¡£FFAͼÏñ·ûºÏÒÔÏÂÌØµã¼´ÈÏΪCNVÐγɣ¬¢ÙÔÚÔìÓ°ÔçÆÚ¼´¶¯ÂöǰÆÚ»ò¶¯ÂöÆÚ¼´ÏÔÓ°¡£¢ÚÓëÊÓÍøÄ¤Ñª¹ÜϵͳûÓÐÁªÏµ¡£¢ÛÓ«¹âËØÑ¸ËÙÉøÂ©£¬ÓÐÒ»¶¨µÄ»ý´æ·¶Î§£¬ºóÆÚÐγɸßÓ«¹âÇø¡£½«¸÷ʱ¼ä¶Î³öÏÖCNV¹âÄý°ßÊýÄ¿Óë¸Ãʱ¼ä¶ÎµÄ¹âÄý°ß×ÜÊýµÄ±ÈÖµ×÷Ϊ¸Ãʱ¶ÎµÄCNV·¢ÉúÂÊ¡£

ºóÐø½øÐй⾵¹Û²ì¡¢×éÖ¯²¡ÀíѧCNVÏà¶Ôºñ¶È²âÁ¿¡¢Í¸Éäµç¾µ¹Û²ì¡£



Óŵ㣺

¼¤¹âÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍ·¢ÉúÂʽϸߣ¬´óԼΪ 60%~70%£¬ÔÚ¹âÄýºó¶ÌÆÚʱ¼ä£¨7d£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¼¤¹â°ßµÄÓ«¹âËØÉøÂ©ÔÚ 10~14d´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬ÊÇĿǰÑÛ¿ÆÓÕµ¼CNV×î³£Óõ͝ÎïÄ£ÐÍ¡£



¶þ
Éú³¤Òò×ÓÓÕµ¼CNVÄ£ÐÍ

°üÀ¨ÊÓÍøÄ¤ÏÂ×¢ÉäÔØÓÐѪ¹ÜÄÚÆ¤Éú³¤Òò×Ó£¨vascular endothelial growth factor£¬VEGF£©»ùÒòµÄÏÙÏà¹Ø²¡¶¾ÔØÌå¡¢ÖØ×éVEGFÃ÷½ºÎ¢Á£ÓÕµ¼CNVÄ£ÐÍ¡¢ÊÓÍøÄ¤ÏÂ×¢Éä¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó£¨basic fibroblastgrowth factor£¬bFGF£©Äý½ºÎ¢Á£ÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÊÓÍøÄ¤ÏÂ×¢ÉäbFGF/Ö¬¶àÌÇÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÂöÂçĤÉÏǻֲÈëbFGFÎ¢ÉøÍ¸±ÃÓÕµ¼ÖíCNVÄ£Ð͵ȡ£ÆäÖÐÊÓÍøÄ¤ÏÂ×¢ÉäÔØÓÐVEGF»ùÒòµÄÏÙÏà¹Ø²¡¶¾£¨adeno-associated virus£¬AAV£©ÔØÌåÓÕµ¼CNVÄ£ÐÍÊǽÏΪÀíÏëµÄÄ£ÐÍ¡£



ÔìÄ£·½·¨1£º

½«2¦Ìl±àÂëÈË VEGF-A165ÏÙ²¡¶¾×¢Éäµ½´óÊóÊÓÍøÄ¤Ï£¬CNV·¢ÉúÂÊΪ95%¡£



ÔìÄ£·½·¨2£º

ÔÚÍÃÑÛÊÓÍøÄ¤ÏÂ×¢Éä5¡Á106IUÔØÓйý±í´ïVEGF-A165ÏÙ²¡¶¾ÔØÌåÓÕµ¼CNVÄ£ÐÍ£¬CNV·¢ÉúÂÊΪ83%¡£



Èý
ת»ùÒò»ò»ùÒòÇóýÓÕµ¼

ת»ùÒòºÍ»ùÒòÇóý½¨Á¢CNVÄ£ÐÍÊÇÒ»ÖÖÐÂÐ˼¼Êõ£¬Õë¶ÔCNV·¢Õ¹µÄ¹Ø¼üÒòËØ½¨Á¢»ùÒò¹¤³ÌÄ£ÐÍ£¬¿É´Ó²»Í¬½Ç¶È·ÖÎö¸÷·Ö×Ó¶ÔCNVÐγɵÄÓ°Ï죬°üÀ¨£º£¨1£©VEGF164RPE65ת»ùÒòСÊ󣻣¨2£©Ë«±¶Ì壨Tet/VMD2/VEGF£©ºÍÈý±¶Ì壨Tet/VMD2/VEGF/An2£©×ª»ùÒòСÊó£¬ÊÓÍøÄ¤¿É¸ß±í´ïVEGF£¬ÈôͬʱÊÓÍøÄ¤ÏÂ×¢ÉäѪ¹ÜÉú³ÉËØ2£¨angiogenin2£¬Ang2£©£¬Äܹ»100%ÐγÉCNV£»£¨3£©Ç÷»¯Òò×ÓCCÀàÊÜÌå2£¨chemokine CC motif receptor 2£¬CCR2£©/Ç÷»¯Òò×ÓCCÀàÅäÌå2£¨chemokine CC motif ligand 2£¬CCL2£©»ùÒòȱʧÓÕµ¼Ð¡ÊóCNVÄ£ÐÍ£¬Æä³ÉÄ£ÂÊ´óÔ¼25£¥£»£¨4£©ÔØÖ¬µ°°×E»ùÒò£¨apolipoprotein E£¬ApoE£©¹ý±í´ïСÊóCNVÄ£ÐÍÊÇÑо¿AMD²¡±äÖÐ×Ô·¢ÐÔCNVÐγɻúÖÆµÄÖØÒªÄ£ÐÍ£»£¨5£©CCL2ºÍCX3CÇ÷»¯Òò×ÓÊÜÌå1£¨CX3C chemokine receptor 1£¬CX3CR1£©»ùÒòȱÏÝСÊ󣻣¨6£©³¬Ñõ»¯ÎïÆç»¯Ã¸1£¨superoxide dismutase 1£¬SOD1£©»ùÒòȱÏÝÀÏ»¯Ð¡Ê󣻣¨7£©¼«µÍÃܶÈÖ¬µ°°×ÊÜÌ壨very low density lipoprotein receptor£¬VLDLR£©¶¨ÏòÍ»±äСÊ󣻣¨8£©ÊÓ×ϺìÖÊ»ùÒòÆô¶¯×Ó/VEGF¹ý±í´ïСÊó¡£


ÓÅȱµã£º

ת»ùÒò»ò»ùÒòÇóýÓÕµ¼µÄCNVÄ£Ð;ßÓÐÓÕµ¼¿ì£¬·¢Éúʱ¼ä¶ÌµÈÓŵ㣬ÓëCNV²¡ÀíÉúÀíѧ¹ØÁªÐÔÇ¿£¬¶ÔCNV·¢Éú»úÖÆµÄÑо¿¾ßÓÐÕë¶ÔÐÔ£¬Í¬Ê±Ñо¿Õ߿ɸù¾Ý²»Í¬ÐèÇóÑ¡ÔñÄ£ÐͲ¢Ð޸IJÎÊý£»È±µãÓÐCNVÓÕµ¼Âʵ͡¢Ãæ»ýС¡¢¼Û¸ñ¹óµÈÎÊÌâ¡£

//
×ܽá


ÔÚÖڶཨÁ¢CNVÄ£Ð͵ķ½·¨ÖУ¬¼¤¹âÓÕµ¼CNVÄ£ÐÍÌõ¼þ½Ï³ÉÊ죬Ñо¿ÀúÊ·¾Ã£¬¿É¿¿ÐԸߣ¬Ó¦Óù㷺¡£ÓÉÓÚ¶¯ÎïÌåÄÚ»·¾³²»Í¬ÓÚÈËÌåÄÚ»·¾³£¬¸÷ÖÖ·½·¨ÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍÒ²½öÄÜÄ£ÄâÈËÀàCNV£¬²»ÄÜÍêÈ«´úÌæÈËÀàCNV·¢Õ¹µÄ×ÔÈ»¹ý³Ì£¬Òò´Ë£¬Ñо¿½á¹û½öÄÜΪCNV·¢²¡ºÍ»úÖÆÑо¿ÌṩʵÑéÀíÂÛÒÀ¾Ý¡£
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ »ù´¡ÉúÎïʵÑéÍâ° µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +4 °®²Áº¹µÄ¿ÉÀÖ±ù 2026-02-28 4/200 2026-03-01 00:38 by èèÇòalter
[¿¼ÑÐ] 304Çóµ÷¼Á +3 52hz~~ 2026-02-28 5/250 2026-03-01 00:00 by 52hz~~
[¿¼ÑÐ] 317Ò»Ö¾Ô¸»ªÄÏÀí¹¤µçÆø¹¤³ÌÇóµ÷¼Á +5 Soliloquy_Q 2026-02-28 8/400 2026-02-28 23:36 by xyx2012xyx
[¿¼ÑÐ] 272Çóµ÷¼Á +3 ²Ä×ÏÓл¯ 2026-02-28 3/150 2026-02-28 22:52 by ms629
[¿¼ÑÐ] »¯¹¤×¨Ë¶348£¬Ò»Ö¾Ô¸985Çóµ÷¼Á +4 ¸¥¸ñ¸ö 2026-02-28 6/300 2026-02-28 22:00 by wang_dand
[¿¼²©] 26É격 +4 ÏëÉ격£¡ 2026-02-26 4/200 2026-02-28 21:37 by limorning
[¿¼ÑÐ] ²ÄÁÏѧµ÷¼Á +5 ÌáÉñ¶¹É³°ü 2026-02-28 5/250 2026-02-28 21:34 by gaoxiaoniuma
[¿¼ÑÐ] 264Çóµ÷¼Á +3 °ÍÀ­°ÍÀ­¸ù556 2026-02-28 3/150 2026-02-28 21:31 by gaoxiaoniuma
[¿¼ÑÐ] 311Çóµ÷¼Á +8 ÄÏåÈ720 2026-02-28 8/400 2026-02-28 21:30 by gaoxiaoniuma
[¿¼ÑÐ] Çóµ÷¼Á +4 repeatt?t 2026-02-28 4/200 2026-02-28 21:16 by gaoxiaoniuma
[¿¼ÑÐ] 284Çóµ÷¼Á +4 ÌìÏÂŸß 2026-02-28 4/200 2026-02-28 21:13 by gaoxiaoniuma
[¿¼ÑÐ] 085600²ÄÁϹ¤³ÌÒ»Ö¾Ô¸Öпƴó×Ü·Ö312Çóµ÷¼Á +8 ³ÔÏüÒ¹1 2026-02-28 10/500 2026-02-28 20:27 by L135790
[¿¼ÑÐ] 298Çóµ÷¼Á +8 È˼äΨÄãÊÇÇå»¶ 2026-02-28 11/550 2026-02-28 20:26 by L135790
[¿¼ÑÐ] 285Çóµ÷¼Á +5 ÂúÍ·´óº¹µÄѧÉú 2026-02-28 5/250 2026-02-28 18:10 by ²ÄÁÏר˶µ÷¼Á£»
[¿¼ÑÐ] 265·ÖÇóµ÷¼Á²»µ÷רҵºÍѧУÓÐÐÐѧÉÏ¾Í +4 ÀñÌö¡Õæ258 2026-02-28 6/300 2026-02-28 16:18 by Çóµ÷¼Ázz
[¿¼ÑÐ] 0856µ÷¼Á +3 ÁõÃÎ΢ 2026-02-28 3/150 2026-02-28 13:22 by houyaoxu
[¿¼ÑÐ] ѰÕÒµ÷¼Á +3 LYidhsjabdj 2026-02-28 3/150 2026-02-28 12:59 by miniwendy
[˶²©¼ÒÔ°] ²©Ê¿×Ô¼ö +6 ¿ÆÑй·111 2026-02-26 9/450 2026-02-28 12:32 by seaskyy
[¿¼ÑÐ] 272Çóµ÷¼Á +3 ÌïÖÇÓÑ 2026-02-28 3/150 2026-02-28 12:31 by Íõ¼ÓºÆto
[˶²©¼ÒÔ°] ¡¾²©Ê¿ÕÐÉú¡¿Ì«Ô­Àí¹¤´óѧ2026»¯¹¤²©Ê¿ +4 N1ce_try 2026-02-24 8/400 2026-02-26 08:40 by N1ce_try
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û